PortfoliosLab logoPortfoliosLab logo
VITL vs. IBRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VITL vs. IBRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vital Farms, Inc. (VITL) and ImmunityBio, Inc. (IBRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VITL achieves a -69.32% return, which is significantly lower than IBRX's 265.15% return.


VITL

1D
-2.68%
1M
-30.89%
YTD
-69.32%
6M
-68.55%
1Y
-68.85%
3Y*
-12.66%
5Y*
-14.53%
10Y*

IBRX

1D
-0.14%
1M
1.69%
YTD
265.15%
6M
245.93%
1Y
170.79%
3Y*
37.68%
5Y*
-16.43%
10Y*
-0.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VITL vs. IBRX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
VITL
Vital Farms, Inc.
-69.32%-15.26%140.22%5.16%-17.39%-28.64%-28.22%
IBRX
ImmunityBio, Inc.
265.15%-22.66%-49.00%-0.99%-16.61%-54.39%19.23%

Correlation

The correlation between VITL and IBRX is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Aug 3, 2020

0.17

The correlation between VITL and IBRX shifts across timeframes, from -0.01 (1 year) to 0.18 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

VITL:

$436.96M

IBRX:

$7.42B

EPS

VITL:

$1.05

IBRX:

-$0.89

PS Ratio

VITL:

0.57

IBRX:

49.38

Total Revenue (TTM)

VITL:

$784.41M

IBRX:

$140.98M

Gross Profit (TTM)

VITL:

$276.18M

IBRX:

$132.23M

EBITDA (TTM)

VITL:

$82.41M

IBRX:

-$196.14M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VITL vs. IBRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VITL
VITL Risk / Return Rank: 44
Overall Rank
VITL Sharpe Ratio Rank: 33
Sharpe Ratio Rank
VITL Sortino Ratio Rank: 22
Sortino Ratio Rank
VITL Omega Ratio Rank: 33
Omega Ratio Rank
VITL Calmar Ratio Rank: 99
Calmar Ratio Rank
VITL Martin Ratio Rank: 55
Martin Ratio Rank

IBRX
IBRX Risk / Return Rank: 8383
Overall Rank
IBRX Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
IBRX Sortino Ratio Rank: 8585
Sortino Ratio Rank
IBRX Omega Ratio Rank: 8282
Omega Ratio Rank
IBRX Calmar Ratio Rank: 8787
Calmar Ratio Rank
IBRX Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VITL vs. IBRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vital Farms, Inc. (VITL) and ImmunityBio, Inc. (IBRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VITLIBRXDifference

Sharpe ratio

Return per unit of total volatility

-1.12

1.63

-2.76

Sortino ratio

Return per unit of downside risk

-2.16

2.76

-4.92

Omega ratio

Gain probability vs. loss probability

0.75

1.33

-0.58

Calmar ratio

Return relative to maximum drawdown

-0.82

4.05

-4.87

Martin ratio

Return relative to average drawdown

-1.50

6.02

-7.52

VITL vs. IBRX - Sharpe Ratio Comparison

The current VITL Sharpe Ratio is -1.12, which is lower than the IBRX Sharpe Ratio of 1.63. The chart below compares the historical Sharpe Ratios of VITL and IBRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


VITLIBRXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.12

1.63

-2.76

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.27

-0.15

-0.12

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.37

-0.12

-0.25

Drawdowns

VITL vs. IBRX - Drawdown Comparison

The maximum VITL drawdown since its inception was -84.20%, smaller than the maximum IBRX drawdown of -97.14%. Use the drawdown chart below to compare losses from any high point for VITL and IBRX.


Loading charts...

Drawdown Indicators


VITLIBRXDifference

Max Drawdown

Largest peak-to-trough decline

-84.20%

-97.14%

+12.94%

Max Drawdown (1Y)

Largest decline over 1 year

-84.20%

-42.44%

-41.76%

Max Drawdown (3Y)

Largest decline over 3 years

-84.20%

-79.34%

-4.86%

Max Drawdown (5Y)

Largest decline over 5 years

-84.20%

-92.83%

+8.63%

Max Drawdown (10Y)

Largest decline over 10 years

-97.03%

Current Drawdown

Current decline from peak

-81.30%

-82.89%

+1.59%

Average Drawdown

Average peak-to-trough decline

-47.19%

-83.91%

+36.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.00%

28.54%

+17.46%

Volatility

VITL vs. IBRX - Volatility Comparison

Vital Farms, Inc. (VITL) has a higher volatility of 30.93% compared to ImmunityBio, Inc. (IBRX) at 22.80%. This indicates that VITL's price experiences larger fluctuations and is considered to be riskier than IBRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VITLIBRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.93%

22.80%

+8.13%

Volatility (6M)

Calculated over the trailing 6-month period

48.39%

89.45%

-41.06%

Volatility (1Y)

Calculated over the trailing 1-year period

61.35%

105.21%

-43.86%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.21%

113.45%

-59.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

53.80%

111.42%

-57.62%

Dividends

VITL vs. IBRX - Dividend Comparison

Neither VITL nor IBRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VITL vs. IBRX - Financials Comparison

This section allows you to compare key financial metrics between Vital Farms, Inc. and ImmunityBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M20222023202420252026
187.16M
44.21M
(VITL) Total Revenue
(IBRX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


VITL and IBRX have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VITL has higher volatility (30.93%) compared to IBRX (22.80%). In terms of maximum drawdown, VITL dropped -84.20% vs IBRX's -97.14%.

IBRX currently has the higher Sharpe Ratio (1.63 vs -1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VITL and IBRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer